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Abstract
To improve health care for older persons, we need to learn more about ageing, e.g. identify protective factors and early mark-
ers for diseases. The Gothenburg H70 Birth Cohort Studies (the H70 studies) are multidisciplinary epidemiological studies 
examining representative birth cohorts of older populations in Gothenburg, Sweden. So far, six birth cohorts of 70-year-olds 
have been examined over time, and examinations have been virtually identical between studies. This paper describes the study 
procedures for the baseline examination of the Birth cohort 1944, conducted in 2014–16. In this study, all men and women 
born 1944 on specific dates, and registered as residents in Gothenburg, were eligible for participation (n = 1839). A total 
of 1203 (response rate 72.2%; 559 men and 644 women; mean age 70.5 years) agreed to participate in the study. The study 
comprised sampling of blood and cerebrospinal fluid, psychiatric, cognitive, and physical health examinations, examina-
tions of genetics and family history, use of medications, social factors, functional ability and disability, physical fitness and 
activity, body composition, lung function, audiological and ophthalmological examinations, diet, brain imaging, as well as 
a close informant interview, and qualitative studies. As in previous examinations, data collection serves as a basis for future 
longitudinal follow-up examinations. The research gained from the H70 studies has clinical relevance in relation to preven-
tion, early diagnosis, clinical course, experience of illness, understanding pathogenesis and prognosis. Results will increase 
our understanding of ageing and inform service development, which may lead to enhanced quality of care for older persons.
Keywords H70 study · Ageing · Birth cohort · Population sample · Health · Study design
Introduction
The number of people aged 60 years and above is globally 
expected to increase from 962 million in 2017 to 2.1 bil-
lion in 2050 [1]. Mental, cognitive and somatic health are 
major determinants of well-being in old age. To improve 
health care for older persons, we need to learn more about 
ageing, e.g. identify protective factors and early markers for 
diseases such as preclinical Alzheimer’s disease. To achieve 
this, it is necessary to conduct comprehensive studies on rep-
resentative samples of older populations who are followed 
longitudinally.
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The Gothenburg H70 Birth Cohort Studies (H70 stud-
ies) are multidisciplinary epidemiological studies examining 
representative birth cohorts of older populations in Goth-
enburg, Sweden. The first study started in 1971. So far, six 
birth cohorts with baseline examination at age 70 have been 
followed longitudinally (see Fig. 1).
Study procedures for birth cohorts 1901–02, 1906–07 and 
1911–12 have been described elsewhere [2, 3]. More than 
700 papers have been published since 1971 (e.g. [4–13]). 
Examinations have been virtually identical between stud-
ies to enhance possibilities of comparisons between birth 
cohorts and examination years. This generates an oppor-
tunity to study time trends in age-related risk and protec-
tive factors, preclinical markers, as well as prevalence and 
incidence of diseases. In addition, new and modern types of 
assessments have been added.
The overarching aim of the H70 studies is to examine 
the impact of mental, somatic and social health on the func-
tional ability and well-being of individuals aged 70 years 
and above, taking into account the complex interactions with 
age, sex, gender, socioeconomic gradients, environmen-
tal exposures, psychosocial, neurobiological, and genetic 
factors.
While there is no single definition of ageing, the phenom-
enon is often defined as an age associated decline of physi-
ological and cognitive functions, and de-tuning of adaptive 
responses, followed by an increase in age-specific mortality 
[14]. Ageing is also related to positive dimensions, such as 
increase in wisdom and life experience. An underlying theo-
retical framework of the multidisciplinary H70 studies is 
the capability approach [15], aiming to illustrate contextual 
conditions of available resources for a specific person or 
population (Fig. 2).
This paper describes the study procedures for the base-
line examination of the Birth cohort 1944, conducted in 
2014–16. This was the largest and most comprehensive H70 
study conducted so far. As in previous examinations, data 




Table 1 demonstrates the eligible, effective and total study 
samples. In line with previous studies in the H70 series, 
study participants were selected based on specific birth 
dates. Information regarding date of birth and residential 
addresses were obtained from the Swedish Tax Agency’s 
population register, which covers all persons registered as 
living in Sweden. In this study, all men and women born 
1944 on dates ending with 0, 2, 5, or 8, and registered 
as residents in Gothenburg were eligible for participation 
(n = 1839). Persons were considered eligible irrespective 
of place of living (e.g. private households, sheltered liv-
ing). Among those eligible, 29 individuals died before the 
examination, 32 had moved from Gothenburg, 53 could 
not speak Swedish, and 58 could not be traced, leaving 
an effective sample of 1667 individuals who were invited 
to participate in the study. The invitation was sent by let-
ter, and included study information and a consent form. 
After approximately one week, a research staff member 
contacted the potential participants by telephone with 
an inquiry about study participation. In cases of no con-
tact, up to three reminders were sent. A total of 1203 
(response rate 72.2%; 559 men and 644 women; mean 
age 70.5 years) agreed to participate in the study. Table 2 
shows demographic factors for all included participants.
Examinations
The study comprised a one-day general examination at the 
Neuropsychiatric Clinic at Sahlgrenska University Hospi-
tal, as well as a number of additional examinations (see 
below). A sample flow chart is illustrated in Fig. 3, and a 





























































































































































Numbers inside boxes: Age and  number of participants.
Number of participants: All birth cohorts are followed longitudinally from 70 years of age (baseline). New participants (not participating at baseline, e.g. new residents in Gothenburg fulfilling the inclusion criteria) have been invited over time in order to keep the 
high level of representativeness . All numbers were extracted from the H70 study database 2018-10-15. 
Examination year: Starting year for each examination wave. 
Fig. 1  Overview of birth cohorts (age inside square) and examination years in the Gothenburg H70 Birth Cohort Studies
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General examinations
The general examinations were conducted at the Neuropsy-
chiatric outpatient department at the Sahlgrenska University 
Hospital and lasted for approximately 8 h (including break-
fast and lunch). Alternatively, the study participants could 
choose to divide the examination between 2 days, or choose 
to be examined only during home visits (n = 46). All inter-
views and tests were conducted by trained research staff in 
the H70 study team. All examinations are presented below.
Blood sampling
Blood sampling was performed by a research nurse in 1192 
individuals (555 men, 637 women; response rate 99.1%) 
after overnight fasting. Fasting status was confirmed by the 
nurse before sampling. The venipuncture was performed in 
the inner elbow while the participant was in an upright sit-
ting position. Blood sampling could not be performed in 11 
individuals (due to e.g. small or deep veins). A maximum of 
120 ml blood was drawn, of which 15 ml was used for blood 
tests. A maximum of 105 ml was aliquoted into serum (after 
20–30 min of coagulation, 5 ml SST tubes were centrifuged 
with 2000 RCF (Relative Centrifugal Force) for 10 min and 
then pipetted into 1.5 ml micro tubes), plasma (10 ml EDTA 
tubes were centrifuged with 2000 RCF (Relative Centrifugal 
Force) in 20 °C for 15 min and then pipetted into 1.5 ml 
MACRO LEVEL
Geographical context, ageism, laws and 
regulations regarding home care, housing, 
assistance, health care, taxes, pensions, 
and support systems
MESO LEVEL
Community, work place, 
home environment, assistive 
devices, social network, 
family and friends
MICRO LEVEL
Mental and physical health, 
cognition, functional ability, 
neurobiology, genetics, sex, 
gender and socioeconomic factors
CAPABILITY
TIME
Age, time period, and birth cohort effects
Fig. 2  The underlying theoretical framework in the Gothenburg H70 Birth Cohort Studies
Table 1  The H70 study sample (participants and non-participants) in 
2014–16
a Residents in Gothenburg (including parts of the municipalities of 
Ale, Kungsbacka, Kungälv, Lerum, Mölndal) according to the Swed-
ish Population Register, Swedish Tax Agency 2014
b Non-participants can be included in more than one self-reported cat-
egory (one person wished to have their data destroyed after participa-
tion)
Women Men Total
Eligible  samplea 961 878 1839
Excluded from sample 67 105 172
Could not be traced 26 32 58
Unable to communicate in Swedish 24 29 53
Not living in Gothenburg 9 23 32
Deceased 8 21 29
Effective sample 894 773 1667
Non-participantsb 250 214 464
No given reason 108 87 195
Reported illness or injury 78 61 139
Regularly health check-ups 66 54 120
Relative declined 13 20 33
Too busy 14 20 34
Fear 18 14 32
Too healthy 8 5 13
Total sample 644 559 1203
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micro tubes) and whole blood (10 ml EDTA tubes pipetted 
into 1.5 ml micro tubes) and were frozen at –80 °C within 
approximately one hour to be saved in a biobank for future 
analyses according to the Swedish Biobank Law (2002:297) 
(biobank registration date: 2005-03-17; Registration Num-
ber: 532 at the National Board of Health and Welfare). All 
study participants gave written consent regarding biobank-
ing. Blood tests included thrombocytes, hemoglobin (Hb), 
Table 2  Sample characteristics 
of 70-year-olds born 1944, 
participating in the H70 study 
2014–16
a Including living with partner, living apart from partner, and married
b Including single and never married/living with partner
c Including paid labour and pensions (SEK)
d Including only those not working and having pension as only income (SEK)
e MMSE has a maximum score of 30
f Including live biological and non-biological children
n Men Women Total
Marital status, % (n)
 Having  partnera 1196 80.5 (449) 62.1 (396) 70.7 (845)
 Widowed 1196 4.3 (24) 11.9 (76) 8.4 (100)
 Divorced 1196 10.4 (58) 22.9 (146) 17.1 (204)
 Singleb 1196 4.1 (23) 3.1 (20) 3.6 (43)
 Other 1196 0.7 (4) 0 (0) 0.3 (4)
Education, % (n)
 Primary education ≤ 9 year 1192 19.3 (107) 15.2 (97) 17.1 (204)
 More than primary education > 9 year 1192 80.7 (447) 84.8 (541) 82.9 (988)
 University degree 1132 31.9 (169) 25.5 (154) 28.5 (323)
Country of birth, % (n)
 Sweden 1195 82.2 (458) 86.5 (552) 84.5 (1010)
 Nordic countries 1195 5.2 (29) 5.3 (34) 5.3 (63)
 European countries 1195 7.5 (42) 6.0 (38) 6.7 (80)
 Other 1195 5.0 (28) 2.2 (14) 3.5 (42)
Average net income (per month), mean
 Individual  incomec 949 19,862 13,718 16,618
 Individual  pensiond 740 17,783 13,047 15,109
 Household  incomec 912 31,974 24,082 27,880
Average net income (per month), median
 Individual  incomec 949 16,500 12,000 14,000
 Individual  pensiond 740 15,000 12,000 13,225
 Household  incomec 912 28,900 22,000 25,000
Paid labour, % (n)
 Working part-time 1195 15.4 (86) 9.9 (63) 12.5 (149)
 Working full-time 1195 4.8 (27) 0.6 (4) 2.6 (31)
 Working in periods 1195 8.1 (45) 5.2 (33) 6.5 (78)
Housing, % (n)
 Sheltered living 1188 2.3 (13) 1.9 (12) 2.1 (25)
Mini-Mental State Examination, mean
 MMSE  scoree 1187 28.6 28.9 28.8
Smoking, % (n)
 Current smoker 1191 7.4 (41) 11.2 (71) 9.4 (112)
 Previous smoker 1191 55.9 (310) 50.0 (318) 52.8 (628)
Having children, % (n)
 Yesf 1185 87.5 (484) 87.0 (550) 87.3 (1034)
Internet, % (n)
 Using internet every day 1137 68.5 (358) 63.5 (390) 65.8 (748)
 Never using internet 1137 12.6 (66) 11.2 (69) 11.9 (135)
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Fig. 3  Sample flow chart for the H70 study 2014–16
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glucose, thyroid function (TSH, T4), kidney function (cre-
atinine), liver function (AST, ALT), lipids (total-, HDL- and 
LDL-cholesterol, triglycerides) and indirect measurement 
of vitamin B12 and folic acid status (homocysteine). Name 
of the assay/reagent and instrument manufacturer for each 
measure can be found in Supplementary 1.
Genetics and family history
Due to a limited amount of blood sampled, DNA extraction 
was impossible to perform for 25 of the total 1192 individu-
als with blood samples. DNA was thus extracted from 1165 
individual samples of whole blood (548 men, 617 women; 
response rate 97.7%). The extraction of DNA from whole 
blood was performed according to standard procedures at 
LGC Genomics in Berlin (Germany). All the DNA samples 
have been genotyped at University College London (UK), 
using the Neuro Consortium Array (neurox2) from Illumina 
(www.illum ina.com). Additional single nucleotide polymor-
phisms (SNPs) in genes of specific interest have been, and 
will be, analyzed at LGC Genomics in Hoddesdon (UK), 
using the KASP genotyping technology. The participants and 
a close informant were asked about family history of demen-
tia, depression, stroke, diabetes mellitus and cardiovascular 
disorders, as described below.
Psychiatric examination
A psychiatric examination was performed in 1194 indi-
viduals (555 men, 639 women; response rate 99.3%). Non-
participants (n = 9) did not perform the examination due to 
several reasons (e.g. declining participation, aphasia or not 
speaking Swedish well enough to respond to the psychiatric 
questions). The semi-structured interview was conducted 
by a psychiatric research nurse, a psychiatrist, or a medical 
doctor, with a mean duration of 30 min. Psychiatric signs 
and symptoms during the past month were rated accord-
ing to the Comprehensive Psychopathological Rating Scale 
(CPRS) [16], and the Mini-International Neuropsychiatric 
Interview (MINI) [17]. The Montgomery-Åsberg Depression 
Rating Scale (MADRS) [18] was derived from the CPRS 
to assess the overall burden of depressive symptoms. Both 
Fig. 4  Study protocol for the 
H70 study 2014–16 PROTOCOL 
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CPRS and MADRS have been found to be valid and reliable 
in older populations [19, 20]. The CPRS subscale, The Brief 
Scale for Anxiety (BSA) [21], was used to assess overall 
burden of anxiety symptoms. Mental and social functioning 
was assessed with the Global Assessment of Functioning 
(GAF) scale [22]. Questions about suicidal feelings were 
asked according to Paykel et al. [23]. The interview also 
comprised questions regarding symptoms of ADHD dur-
ing early life and childhood [24], history of previous mental 
disorders; periods of hypomania according to Angst [25], the 
Yale-Brown Obsessive–Compulsive Scale [26], symptoms of 
depression and anxiety (panic, general anxiety, agorapho-
bia), specific phobias, social anxiety disorder, post-traumatic 
stress syndrome, psychotic symptoms, thoughts about death 
and suicide, feelings of loneliness, periods of stress in rela-
tion to family and work, cognitive symptoms, appetite and 
weight loss, and sleep. The examiner also rated global sever-
ity of mental health problems and a number of observed 
psychiatric symptoms. All diagnoses for psychiatric disor-
ders (e.g. depression, generalized anxiety, specific and social 
phobia, bipolar disorder, psychosis, obsessive–compulsive 
disorder, and traumatic stress disorder) followed the Diag-
nostic and Statistical Manual of Mental Disorders, DSM-IV 
[27], DSM-IV-TR [28], and DSM-5 [29] criteria as closely 
as possible. Questions regarding mental health were also 
asked in self-rating questionnaires (see Table 3: GAF; Pho-
bias; PSS-14).
Cognitive battery
A clinical cognitive examination was performed in 1196 
individuals (557 men, 639 women; response rate 99.4%). 
The examination was conducted by a psychiatric nurse, a 
psychiatrist, or a medical doctor, with a total duration of 
approximately 25 min. The examination comprised tests 
of word fluency (animals), naming 12 objects, copying 
five figures, finger agnosia, orientation, selective atten-
tion, understanding proverbs, ideational apraxia, memory 
(remembering 12 objects, word memory list, two last prime 
ministers), ability to follow instructions. Cognitive func-
tion was rated in accordance with a Swedish version of the 
Mini-Mental State Examination (MMSE) [30], the Gottfries 
Bråne Steen-scale (GBS) [31], as well as global ratings. 
Specific assessments relevant for dementia diagnosis, such 
as recent and remote memory, semantic memory, concentra-
tion, apraxia, spoken language, language comprehension, 
word finding difficulties, and other intellectual functions 
were performed, as well as assessments with the Clini-
cal Dementia Rating scale (CDR) [32], and Alzheimer’s 
Disease Assessment Scale-Cognitive (ADAS-COG) [33]. 
Dementia was diagnosed following the Diagnostic and Sta-
tistical Manual of Mental Disorders DSM III-R [34] criteria 
as closely as possible using information from the clinical 
cognition examination and information from key informants 
(see below). We also assessed the neurocognitive domains 
described in DSM-5 (complex attention, executive func-
tion, learning and memory, language, perceptual-motor, and 
social cognition) [29].
A more detailed psychometric cognitive examination 
that included questions about subjective memory as well 
as testing of multiple cognitive domains was performed 
in 1173 individuals (547 men, 626 women; response rate 
97.5%). The examination was conducted by research staff 
members, all trained by a psychologist, with a total dura-
tion of approximately 60 min. The subjective part included 
questions concerning participant’s everyday memory, expe-
riences of memory decline, satisfaction with own memory, 
everyday memory problems, memory training, and engage-
ment in cognitively demanding recreational activities, such 
as chess, bridge, crossword-puzzles, and reading habits. The 
cognitive test battery included several cognitive measure-
ments intended to cover a broad range of different cogni-
tive abilities. Memory in Reality (MIR) [35], Supra-span 
memory test (BUS II) [36], and Thurstone’s Picture Memory 
[37] measured memory abilities. Digit Span Forward and 
Backward test [38] measured short term memory and execu-
tive functioning. Figure Identification—Psif [39] measured 
mental speed, and Figure Logic (SRB 2) [39] measured 
inductive reasoning. Controlled Oral Word Association—
FAS (COWA-FAS) [40] measured verbal fluency and Block 
Design (Koh’s Block Test) [38] measured spatial ability. 
The Clock Test [41] was originally developed for dementia 
screening and measured a wide range of cognitive abilities 
including executive functioning [42]. Most of the tests are 
part of the Dureman and Sälde (1959) psychometric test 
battery [43] that was widely used in Sweden at the start of 
the H70 study 1971–72.
General health interview
A general health interview was performed in 1199 individ-
uals (558 men, 641 women; response rate 99.7%), with a 
total duration of approximately 30 min. The interview was 
conducted by a research nurse or medical doctor, and com-
prised questions about health care, self-rated health, pain 
and fatigue, weight at age 20 and 50, current and past health 
issues (e.g. stroke/TIA, cancer, and a number of cardiovas-
cular, respiratory, metabolic, endocrine, neurological, mus-
culoskeletal, gastrointestinal, kidney, genitourinary, blood, 
eye and ear diseases) and treatment history. It also included 
questions about specific symptoms, e.g. chest pain accord-
ing to the Rose angina questionnaire [44], breathlessness, 
dizziness/vertigo, headache, joint and low-back pain, falls 
and fractures, head trauma, dental health, hearing and eye 
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sight, urinary and fecal incontinence, sexual behavior, age 
of menarche and menopause, hormonal and contraceptives 
use, and alcohol, drug and tobacco use.
Questions regarding self-rated health, substance use, and 
factors associated with physical health were also asked in 
self-rating questionnaires (see Table 3: SF-36, AUDIT and 
DUDIT).
Medications
A total of 1200 individuals (559 men, 641 women; 
response rate 99.8%) reported their medications, includ-
ing dosages and treatment indications. Participants were 
also asked to bring their medication lists. The medications 
were classified according to the Anatomical Therapeutic 
Chemical (ATC) classification system recommended by the 
WHO [45].
Physical examination
Physical examinations were carried out by research nurses 
in 1200 individuals (559 men, 641 women; response rate 
99.8%), with a total duration of approximately 45 min. 
The examination was conducted by a research nurse, and 
comprised measures of length, weight, waist and hip cir-
cumference, ankle pressure (Minidop ES-100VX Hadeco), 
and pulse frequency. Systolic and diastolic blood pressure 
were recorded in the right arm in the sitting position after 
5 min rest using a standard cuff (Umedico). Blood pressure 
was also recorded in the supine position after 5 min rest, 
and after one and 3 min in the standing position. The neu-
rological examination included the Romberg test [46], the 
Grasset test, and evaluation of hypokinesia, rigidity, tremor, 
and a number of other motor disturbances. Electrocardiog-
raphy (ECG) was performed in 1193 individuals (556 men, 
637 women; response rate 99.2%) (SCHILLER AT-2 plus 
or SCHILLER AT-102 plus at the outpatient clinic, and 
SHILLER AT-101 during home visits). Non-participants 
(n = 10) did not perform the examination due to several rea-
sons (e.g. declining participation or technical reasons). The 
ECG was coded according to the Minnesota code system 
[47].
Body composition examination
Bioelectrical impedance was performed in 1147 individuals 
(533 men, 614 women; response rate 95.3%). Non-partici-
pants (n = 56) did not perform the examination due to several 
reasons (e.g. having pace-maker or wheelchair). The exami-
nation was used to measure individual body composition 
(Body Composition Analyzer TANITA T7063 09010007 at 
the outpatient clinic, and TANITA T6360 07060054 during 
home visits). Participants were also asked to take part in 
a more comprehensive body composition examination (see 
below).
Lung function
A total of 865 individuals (412 men, 453 women; response 
rate 71.9%) performed a lung function examination. This 
comprised spirometry (Spirare SPS310 sensor and Spirare 
3 software, Diagnostica AS, Oslo, Norway) without bron-
chodilator administration according to the American Tho-
racic Society/European Respiratory Society standards [48]. 
Maximum forced volume capacity (FVC), forced expiratory 
volume in 1 s (FEV1), peak expiratory flow (PEF), forced 
expiratory flow (FEF25, 50, 75), maximal (mid-) expiratory 
flow (MMEF), slow vital capacity (SVC), and forced expira-
tory time (FET) were measured.
As in previous H70 studies, FVC and FEV1 were also 
measured with a Micro Medical portable spirometer (Micro 
Medical Ltd, Rochester, Kent, UK) [49], and peak expira-
tory flow (PEF) was recorded with a Mini-Wright Peak Flow 
Meter (Clement Clarke International Ltd, Harlow, Essex, 
UK) [50], where participants were asked to exhale with a 
maximally forced effort from a position of maximal inspira-
tion. A total of 1098 (515 men, 583 women; response rate 
91.3%) individuals performed the Micro Medical portable 
spirometer test (FVC, FEV1), and 1099 (518 men, 581 
women; response rate 91.4%) performed the Mini-Wright 
Peak Flow Meter test (PEF). Each participant performed the 
PEF test three times and the highest value was used as the 
final result. Of those who did not perform the lung function 
examinations, several reasons were reported (e.g. technical 
reasons or physically unable to take the test). Only the Micro 
Medical portable spirometer and Mini-Wright Peak Flow 
Meter could be performed during home visits.
Audiological examination
An audiological examination was performed in 1116 indi-
viduals (523 men, 593 women; response rate 92.8%), with 
a total duration of approximately 30 min. Non-participants 
(n = 87) did not perform the examination due to several 
reasons (e.g. declining participation or technical reasons). 
The examination could not be performed during home 
visits. The audiological examination was conducted by a 
research nurse in a quiet office setting, and comprised pure 
tone audiometry, which measures the sensitivity of the ear 
to tones of differing frequency; wide band tympanometry, 
measuring the condition of the middle ear and the mobility 
of the ear drum and the construction bones; and otoscopy. 
Audiometry (air-conduction only) was carried out with an 
automated method using Sennheiser HDA200 headphones. 
The examination maps hearing loss caused by lesions and 
diseases in the middle ear and the cochlear nerve. This type 
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of audiometry is gold standard for clinical practice and for 
epidemiological purposes. Questions were also asked about 
perceived hearing disability, hearing aid use and tinnitus. A 
subsample performed a more comprehensive audiological 
examination (see below).
Ophthalmic examination
Near vision acuity was tested with a Jaeger eye chart in 
1181 individuals (549 men, 632 women; response rate 
98.2%) with the participants’ own reading glasses if any. 
The general examination also included questions about ocu-
lar morbidity and vision. Questions regarding visual-related 
quality of life were also asked in self-rating questionnaires 
(see Table 3: VFQ-25). A subsample performed a more com-
prehensive ophthalmic examination (see below).
Functional ability and disability
An interview assessing functional ability and disability 
was performed in 1197 individuals (558 men, 639 women; 
response rate 99.5%). The interview was conducted by a 
research nurse, with a total duration of approximately 
20 min. Difficulty in self-care tasks or activities of daily 
living (ADL) was either self-assessed, based on observations 
by the research nurse, or from information from staff and 
carers. Several instruments were used. The Barthel Index 
of Activities of Daily Living [51–53] included ten domains 
of function (bowels, bladder, grooming, toilet use, feeding, 
transfer, mobility, dressing, stairs, and bathing). Response 
options were either independent or dependent/unable. A 
summary score ranged from zero (low function, depend-
ent) to 100 (high function, independent). The Katz Index of 
Independence in ADL [54] included six domains of function 
(bathing, dressing, toileting, transferring from bed to chair, 
continence, and feeding), with response options independ-
ent or dependent. A summary score ranged from zero (high 
function/independent) to six (low function/dependent). Inde-
pendent living skills or instrumental activities of daily living 
(IADL) were measured with the Lawton Instrumental Activi-
ties of Daily Living Scale (IADL) [55]. The scale provides 
information about functional skills necessary to live in the 
community, and includes eight domains of function (ability 
to use the telephone, shopping, food preparation, housekeep-
ing, laundry, mode of transportation, responsibility of own 
medications, and the ability to handle finances). Response 
options ranged from fully independent to completely unable/
incapable. A summary score ranged from zero (low func-
tion, dependent) to eight (high function, independent). The 
examination also included assessment of a number of other 
functions used in previous H70 studies. The “ADL staircase” 
included a mix of questions from the Katz and Lawton scales 
with response options independent/dependent. Questions 
were also asked about use of assistive devices, ability to 
pick up things from the floor, ability to move around indoors 
and outdoors with and without assistive devices, past year 
travel abroad, car driving, and use of community health care, 
services, and personal care needs including help from family 
and friends. Questions regarding helping others with daily 
activities were also asked in self-rating questionnaires (see 
Table 3: Relationships).
Physical fitness and physical activity examination
An examination of fitness and physical activity was per-
formed in 1173 individuals (545 men, 628 women; response 
rate 97.5%), with a total duration of approximately 30 min. A 
physiotherapist performed the examination, which included 
fitness tests and an interview regarding physical activity. 
Self-selected and maximum gait speed [56] for 30-meter 
indoors with standing start were measured (meter/second), 
as well as achieved walking distance (meters) during a six-
minutes indoor walking test [57]. Pulse and oxygen uptake 
were measured at four time points with a pulse oximeter 
(NONIN Onyx II model 9550 oximeter). Grip strength 
was tested with a Martin Vigorimeter [58] and a JAMAR 
dynamometer (sub-sample) [59], with the shoulder joint in 
a neutral position. The test was repeated three times for each 
hand, and the highest value of the best hand was used as 
outcome. Timed chair-stand [60] tested the ability to stand 
up and sit down from a chair (height 43 cm) five times in a 
row as quickly as possible (five-repetition sit-to-stand-test) 
[61]. The total time (in seconds) was used as outcome. One-
leg static balance [62] tested the ability to stand on one leg 
without shoes, for a maximum of 30 s, with eyes open. The 
test was interrupted if the individual moved from the stand-
ardized position and three trials for each leg were allowed. A 
dynamic balance test [63, 64] was also performed, in which 
the study participants were instructed to walk along the lines 
of a floor-painted “8” two times. Both time (in seconds) and 
number of inaccurate steps (counting left and right) were 
registered. A stair climbing test was conducted, as described 
in [65], testing the ability to climb onto a box of 50 cm (or 
40, 30, 20 to 10 cm, if unable to climb the box of 50 cm) 
with or without support using a handle attached to the wall. 
Physical activity was assessed by an interview including 
the 6-grade physical activity scale [66] and study specific 
questions regarding walking habits and types of physical 
activities. The examination also comprised questions about 
walking habits, self-rated fitness, level of physical activity 
at certain ages (lifetime), participation in competitive sports 
(lifetime), and type of activities performed during the past 
12 months. Questions regarding physical activity were also 
asked in a self-rating questionnaire (see Table 3: IPAQ).
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Social factors
An interview regarding social factors was performed in 1198 
individuals (558 men, 640 women; response rate 99.6%), with 
a total duration of approximately 30 min. The interview was 
conducted by a research nurse, and comprised questions about 
past and present marital status and marital satisfaction, rela-
tionships with friends, partner’s physical and mental health, 
and need of assistance, housing and neighborhood, noise in 
surrounding, place of birth and family origin, family constel-
lation and number of children, grandchildren, and siblings, 
and death of children, grandchildren, siblings or friends. 
Questions were also asked about serious illness and social 
problems in children and grandchildren, conflict with children 
or grandchildren and time spent helping them in everyday life, 
parents’ age at birth of participant, parents’ age at death, and 
own age at death of parent. Age at time of move to Gothen-
burg was recorded for those not born in the city. Study partici-
pants were also asked about childhood conditions, education, 
past and present working conditions, retirement and reaction 
to retirement transition, and partner’s work or retirement sta-
tus, and current feelings of loneliness. Questions regarding 
social factors were also asked in self-rating questionnaires 
(see Table 3: Activities, Relationships, Income, and Work), 
which included questions about e.g. hobbies, leisure time 
activities, and use of internet and computers.
Self‑rating questionnaires
All participants were asked to answer 19 self-rating question-
naires. Number of participants answering each questionnaire 
can be seen in Table 3. The self-rating questionnaires could 
be filled out during the day of the general examinations or at 
home. In the latter case, questionnaires were sent back by mail. 
A continuous quality assurance comprising completion of 
unanswered questions was made by the research staff by tele-
phone and letter. A total of 47 participants (23 men, 24 women) 
declined to answer all questionnaires (due to cognitive decline, 
impaired vision, poor health, or unwillingness to answer).
Final rating of medical burden
Following the general examination, an overall quantitative 
rating of medical burden was made using the Cumulative 
Illness Rating Scale for Geriatrics (CIRS-G) [67, 68]. Medi-
cal problems were rated by organ system (heart, vascular, 
hematopoietic, respiratory, eyes, ears, nose, throat and lar-
ynx, upper gastrointestinal tract, lower gastrointestinal tract, 
liver, renal, genitourinary, musculoskeletal and skin, neu-
rological, endocrine, metabolic and breast, and psychiatric 
illness) with a scale ranging from 0 to 4, from no problems 
to extremely severe.
Additional examinations
After the general examination, all study participants were 
asked to take part in additional examinations at a later date: 
close informant interview, dietary examination, body com-
position examination (DXA, BIS), computed tomography 
(CT-scan) and magnetic resonance imaging (MRI) of the 
brain, and lumbar puncture (LP). Subsamples were invited 
to extended audiological, extended ophthalmological exami-
nations, and qualitative studies. All additional examinations 
are presented below.
Close informant interview
All participants were asked if they would like to supply con-
tact information for a close informant for a collateral interview 
by research staff. If the participant was not able to provide this 
information due to dementia, a close informant was sought 
in other ways (e.g. through staff at residential care facilities). 
A close informant interview was performed by telephone 
for 973 individuals (470 men, 503 women; response rate 
80.9%). Among those not having a close informant interview 
(n = 230), several reasons were reported (e.g. did not have 
any close informants to contact, close informants declined 
to participate). The interview was conducted by a research 
nurse or psychologist, during a mean of 45 min. The close 
informant was a spouse or partner in 606 cases, a daughter in 
176 cases, a son in 79 cases, and others (e.g. friend, grand-
child, or residential care staff) in 53 cases. The mean inter-
val between the general examination and the close informant 
interview was 209 days. The close informant interview was 
semi-structured, and included the Informant Questionnaire 
on Cognitive Decline in the Elderly (IQCODE) [69], which 
assesses changes in everyday cognitive function. The inter-
view also comprised questions regarding cognitive symptoms 
and functional abilities (e.g. memory, spatial orientation, lan-
guage, general intellectual symptoms, eating habits, inconti-
nence, and a number of activities of daily living), as well as 
psychiatric symptoms (e.g. personality changes, irritability 
and aggressive behavior, motivation, emotions, depressive, 
anxiety, obsessive compulsive, psychotic and other psychiatric 
symptoms), and age at onset, course and cause of symptoms 
or disabilities. The interview also included questions regard-
ing a number of background factors (e.g. education, smoking, 
snoring, family situation, and life events), history of diseases 
(e.g. cerebrovascular and cardiovascular diseases, dementia, 
head trauma, alcohol abuse, infectious diseases, deficiency 
states, hypo- and hyperthyroidism, chronic bronchitis and 
asthma, diabetes mellitus, Parkinson’s disease, normal pres-
sure hydrocephalus, hip fracture), and family history of dis-
eases (dementia, depression, stroke, cardiovascular diseases, 
diabetes mellitus). In cases of dementia, questions were also 
asked regarding course and age at onset.
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Dietary examination
All study participants without dementia were invited to 
take part in a dietary examination. The examination was 
performed in 861 individuals (385 men, 476 women; 
response rate 71.6%) with a total duration of approximately 
60–90 min. Non-participants (n = 342) did not perform the 
examination due to several reasons (e.g. declining participa-
tion, poor health, lack of time or no response). A dietician 
performed a semi-structured interview capturing habitual 
Table 3  Overview of the self-rating questionnaires included in the H70 study 2014–16
a Self-constructed questionnaire
b Only a subsample (n = 295) were asked to answer the Cesarec Marke Personality Scheme (CMPS), to increase comparability of personality 
traits measured in previous phases of the H70 study
Instrument n (Men, women; response rate) Content References
Capability
 ICECAP-O 1040 (482 men, 558 women; 86.5%) The ICEpop CAPability measure for Older people comprises five questions 
measuring individual quality of life with a capability approach
[84]
Health
 GAF 1130 (519 men, 611 women; 93.9%) The Global Assessment of Functioning comprises two questions measuring the 
social, occupational, and psychological functioning
[22]
 PHOBIAS 1134 (522 men, 612 women; 94.3%) Specific phobia is measuring with 60 items (e.g. snakes, elevators, blood) a
 PSS-14 1135 (523 men, 612 women; 94.3%) The Percieved Stress Scale comprises 14 questions measuring general perceived 
stress
[85]
 SF-36 1137 (524 men, 613 women; 94.5%) The Short-Form Health Survey comprises 36 questions measuring physical, 
mental and social health
[86]
 SOC 1138 (525 men, 613 women; 94.6%) The Sense of Coherence questionnaire comprises 13 questions measuring com-
prehensibility, manageability, and meaningfulness
[87]
 VFQ-25 1139 (525 men, 614 women; 94.7%) The Visual Function Questionnaire comprises 25 questions measuring global 
vison, difficulty with near and distance activities, limitations in social func-
tioning, role limitations, dependency on others and mental health symptoms 
due to vision, driving difficulties and ocular pain
[88]
Life style
 ACTIVITIES 1140 (524 men, 616 women; 94.8%) Leisure time activities and interests, religious belief, and media consumption are 
measured with 60 questions
a
 AUDIT 1134 (520 men, 614 women; 94.3%) The Alcohol Use Disorders Identification Test comprises 10 questions about 
alcohol consumption measuring frequency, amount (standard drinks), and 
alcohol-related dependence, consequences and harm
[89]
 DIET 1142 (526 men, 616 women; 94.9%) Dietary pattern (quantity and variety when consuming specific food products) is 
measured with 16 questions
a
 DUDIT 1137 (524 men, 613 women; 94.5%) The Drug Use Disorders Identification Test comprises 10 questions about drug 
consumption (e.g. cannabis, cocaine or overconsumption of prescribed medi-
cation) measuring frequency, amount and dependence, consequences and harm
[90]
 EDI 1143 (528 men, 615 women; 95.0%) Body image and emotions attitudes towards eating are measured with 13 ques-
tions
[91]
 IPAQ 1040 (482 men, 558 women; 86.5%) The International Physical Activity status Questionnaire comprises 10 questions 
measuring physical activity during the past 7 days
[92]




 CMPSb 242 (116 men, 126 women; 82.0%) The Cesarec Marke Personality Scheme comprise 165 questions measuring the 
personality traits achievement, affiliation, aggression, defense of status, guilt 
feelings, dominance, exhibition, autonomy, nurturance, order and succorance
[93]
 EPI 1140 (526 men, 614 women; 94.8%) The Eysenck Personality Inventory comprises 57 questions measuring the per-
sonality traits extraversion and neuroticism
[94]
 NEO-FFI-3 1141 (524 men, 617 women; 94.8%) The NEO Five Factor Inventory comprises 60 questions measuring the personal-
ity traits neuroticism, extraversion, openness, agreeableness, and conscien-
tiousness
[95]
 PN-SRI 1138 (526 men, 612 women; 94.6%) The Positive–Negative Sex-Role Inventory comprises 24 questions measuring 
gender coded personality traits within femininity, masculinity, and androgyny
[96, 97]
Socioeconomic status
 INCOME 1121 (518 men, 603 women; 93.2%) Individual income and total household income are measured with six questions a
 WORK 1127 (518 men, 609 women; 93.7%) Previous and current working states, together with ratings of subjective work 
capacity are measured with three questions
a
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dietary intake (food and beverages) during the past 3 months. 
The interview, which was conducted at the outpatient clinic 
or during a home visit, included not only open-ended ques-
tions about usual food patterns, but also structured ques-
tions in order to capture total intake as closely as possible. 
Dietary intake, defined as energy and nutrient intake, and 
food pattern were measured by the diet history (DH) method 
described elsewhere [70, 71]. Data from DH interviews was 
processed using the Swedish National Food Agency’s nutri-
ent database (The Swedish Food Composition Database), to 
estimate energy and nutrient intake.
Extended body composition (DXA, BIS)
All study participants were invited to take part in a body 
composition examination. The examination was performed 
in 993 individuals (402 men, 591 women; response rate 
82.5%) with total duration of approximately 20 min. Non-
participants (n = 210) did not perform the examination due to 
several reasons (e.g. declining participation, or technical rea-
sons or no contact). The body composition examination was 
conducted by a nurse at Sahlgrenska University Hospital, 
where dual energy X-ray absorptiometry (DXA) was meas-
ured using a Lunar Prodigy scanner (Scanex, Helsingborg, 
Sweden) [72]. A full body scan analyzed the amount of body 
fat, lean soft tissue, and bone mineral content. Fat-free mass 
was defined as the sum of lean soft tissue and bone mineral 
content. Appendicular lean soft tissue was defined as the 
sum of lean soft tissue in arms and legs. Body composi-
tion was measured by bioelectrical impedance spectroscopy 
(BIS) using an ImpediMed SFB7 device. BIS measures body 
composition based on the principle that tissues in the body 
conduct electric current. BIS calculated total body water 
and the amount and distribution of intracellular water and 
extracellular water via electrodes on hand/wrist and foot/
ankle. Thus, fat free mass was estimated. Resistance and 
reactance measurements were made over a wide range of 
frequencies [73, 74]. Manufacturer’s proprietary software 
was used to calculate Cole Plot parameters and body com-
position estimates.
Computed tomography (CT‑scan) and magnetic resonance 
imaging (MRI)
All study participants were invited to take part in a brain 
imaging examination, conducted at the Aleris Clinic in Goth-
enburg. Participants underwent both computed tomography 
(CT, approximately 5 min) and magnetic resonance imag-
ing (MRI, approximately 40 min) during the same session. 
Number of participants and the acquisition parameters for 
CT and MRI can be observed in Table 4. The CT examina-
tion was performed in 915 individuals (response rate 76.1%), 
and the MRI examination in 791 individuals (response rate 
65.8%). Participants were interviewed for safety procedures 
(e.g. incompatible implant devices such as pacemakers) 
and informed consent was obtained. Non-participants did 
not perform the examination due to several reasons (e.g. 
declining participation, no response or expressing fear or 
discomfort). For those willing to undergo MRI, five could 
not participate due to contraindications (i.e. pace-makers). 
The examination was interrupted on 22 occasions due to 
claustrophobia and three occasions due to noise discomfort.
The CT data was acquired on a 64-slice Philips Ingenu-
ity CT system (Philips Medical Systems, Best, Netherlands). 
The MRI data was acquired on a 3.0T Philips Achieva system 
(Philips Medical Systems). The MRI protocol consisted of a 
T1 3D-isotropic acquisition (T1W_3D_TFE) for structural 
changes, a fluid attenuation inversion recovery (FLAIR) for 
detection of white matter pathology, and T2 weighted images 
(t2w) to exclude other types of pathologies such as tumors. 
Table 4  Computed tomography (CT-scan) and Magnetic Resonance Imaging (MRI) acquisition parameters in the H70 study 2014–16
CT n (men/
women)
Slice thickness Rot. time Pitch Increment Acquisition 
matrix (mm)
Filter Windowing


















377/414 1 7.2 3,2 – 250 × 250 256 × 256 9
3D_FLAIR sag 
SENSE
376/414 2 4800 280 1650 250 × 237 250 × 250 90
T2w (tra) 376/413 4 3000 80 – 288 × 223 230 × 230 90
VEN_BOLD_
HR (SWI)
376/413 1 14,59–17,60 20,59–24,99 – 220 × 222 220 × 220 10
rs-fMRI 365/396 4 2500 14 – 64 × 64 240 × 240 70
High-ISO DTI 365/394 3 7340 83 – 112 × 112 224 × 224 90
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Further, a Venus bold sequence was acquired for the detec-
tion of microbleeds. White matter integrity was examined 
using diffusion tensor imaging (DTI) sequence and functional 
changes were observed with resting-state fMRI sequence.
Cerebrospinal fluid (CSF) sampling
All study participants were invited to take part in CFS sam-
pling via a lumbar puncture (LP). A total of 430 individuals 
consented (response rate 35.7%), but there were pharmaco-
logical contraindications for 108 persons (e.g. anticoagu-
lant therapy, immune modulation, cancer therapy), leaving 
322 participants (166 men, 156 women). Of those unwill-
ing to participate (n = 773), several reasons were reported 
(e.g. expressing fear or anticipated discomfort regarding 
the examination or its results). The LP, with total duration 
of approximately 30 min, was conducted by a consultant 
neurologist/psychiatrist at the Neuropsychiatric outpatient 
department at the Sahlgrenska University Hospital. Prior to 
the examination, each participant had to undergo CT and/
or MRI examination in order to detect possible contradic-
tions. All CSF samples were collected by LP in the morning 
from the L3/L4 or L4/L5 interspace. One CSF aliquot was 
used for CSF analyses [75], including a CSF cell count and 
the CSF/serum albumin ratio, after which a total of 10 ml 
of CSF was collected in a polypropylene tube and immedi-
ately transported to the local laboratory for centrifugation at 
1800 RCF (Relative Centrifugal Force) at 20 °C for 10 min. 
The supernatant was gently mixed to avoid possible gradi-
ent effects, aliquoted in polypropylene tubes and stored at 
− 70 °C. CSF samples in the present study underwent one 
freeze–thaw cycle prior to analysis. CSF total-tau, phospho-
tau and Aβ42 were analyzed directly after 1 to a few days at 
− 20 °C. CSF total tau and tau phosphorylated at threonine 
181 (p-tau) were determined using a sandwich enzyme-
linked immunosorbent assay (ELISA)  (INNOTEST® htau 
Ag and PHOSPHO_TAU (181P), (Fujirebio, Ghent Bel-
gium) as previously described [76, 77]. CSF amyloid-β42 
(Aβ42) peptide was measured using a sandwich ELISA 
 (INNOTEST® β-amyloid1-42), specifically constructed to 
measure amyloid-β peptides starting at amino acid 1 and 
ending at amino acid 42 [78]. All measurements were per-
formed by board certified laboratory technicians blinded to 
clinical data. Laboratory procedures were accredited by the 
Swedish Board for Accreditation and Conformity Assess-
ment. The laboratory technicians were blinded to clinical 
data.
Extended audiological examination (see 
also Supplementary 2)
A subsample of 305 participants, born on dates ending 
with 2 and 5 of each month, were invited for an extended 
audiological examination conducted at the Audiology Unit, 
Sahlgrenska Academy. Of those invited, 251 participants 
(113 men, 138 women; response rate 82.3%) underwent the 
examination with total duration of approximately 90 min.
Extended ophthalmic examination (see 
also Supplementary 3)
A subsample of 631 participants, born on days ending with 
0, 2, 5 and 8 (born January-April), and 5 and 8 (born May-
December), were invited for an ophthalmic examination 
conducted at Sahlgrenska University Hospital, Mölndal. 
Of those invited, 561 participants (266 men, 295 women; 
response rate 88.9%) underwent the examination with a total 
duration of approximately 90 min.
Qualitative studies (see also Supplementary 4)
Purposive sub-samples of study participants also took part 
in qualitative studies (focus groups or individual interviews).
Registry data (see also Supplementary 5)
The H70 study is permitted to be linked to a large number 
of databases from different state agencies in Sweden (e.g. 
including data regarding participants’ birth records, visits 
to early child care, schooling, drafting records for 18-year-
old men).
Ethical approval and informed consent
The H70 study was approved by the Regional Ethical Review 
Board in Gothenburg (Approval Numbers: 869-13, T076-
14, T166-14, 976-13, 127-14, T936-15, 006-14, T703-14, 
006-14, T201-17, T915-14, 959-15, T139-15), and by the 
Radiation Protection Committee (Approval Number: 13-64).
Study participants provided written informed consent 
prior to the general and additional examinations. Consent 
was obtained from a relative if the participant was unable to 
provide own consent. Travel checks for local transportation 
were offered upon request. Taxis were booked and pre-paid 
by the study for participants in need of assisted transporta-
tion. All participants examined at the Neuropsychiatric out-
patient department were offered complimentary breakfast, 
lunch and afternoon snack. No other financial compensation 
was given.
Results on biomarkers (blood samples, ECG, blood pres-
sure, CT/MRI scans and lumbar puncture) were communi-
cated to the study participants by letter. With the approval of 
the participant, a copy was sent to the primary care facility. 
Abnormal test results, previously undetected disease and 
acute medical conditions were first handled by the respon-
sible study physician, who initiated appropriate referrals. 
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Upon detection of acute medical conditions, study partici-
pants were transported to the emergency service at the Sahl-
grenska University Hospital in Gothenburg.
Data management
Data are stored at the Institute of Neuroscience and Physiol-
ogy at the University of Gothenburg according to GDPR reg-
ulations. A database group is responsible for quality control, 
data cleaning, and data delivery. Data will be made available 
to outside researchers through our standard security process, 
and according to established GDPR data sharing guidelines. 
Requests for data will be considered by the H70 study data 
sharing committee on the basis of scientific priorities and 
overlapping interests. Contact information can be found at 
www.epine p.gu.se. In line with the FAIR Principles, infor-
mation about the studies, selected questionnaires and meta-
data are posted at the Swedish National Data Service (www.
snd.gu.se). The database is also part of NEAR (National 
E-infrastructure for Aging Research in Sweden) financed by 
the Swedish Research Council.
Discussion
The Gothenburg H70 Birth Cohort Studies comprise lon-
gitudinal examinations of older birth cohorts born between 
1901 and 1944. The examination of 70-year-olds born 1944 
was the largest and most comprehensive study conducted 
so far, comprising more than 1200 persons. The sample was 
highly educated (almost 30% had a university degree), and 
had high cognitive function (mean MMSE score 28.8). Cur-
rent employment (at least part time) was reported by one-
fifth. Almost 90% had children, 71% had a current partner, 
two-thirds used internet daily, and only 2% had sheltered 
living. Thus, it is a population sample with high cognitive 
and social functioning.
Researchers involved in the multidisciplinary studies 
include psychiatrists, molecular biologists, neurologists, 
geriatricians, audiologists, ophthalmologists, dieticians, 
rheumatologists, health care professionals, public health 
professionals, physiotherapists, occupational therapists, epi-
demiologists, geneticists, neuroradiologists, neurochemists, 
media researchers, historians, psychologists, sociologists 
and economists. The diverse nature of the research team 
reflects the complexity of the ageing process and the need 
for comprehensive studies examining relationships between 
various age-related factors and health related outcomes on 
micro, meso, and macro levels. Several challenges need to 
be addressed when conducting comprehensive longitudinal 
population based studies.
One challenge is participant exhaustion. The magnitude 
of the study may be perceived as demanding, especially 
for those having a high burden of disease. However, our 
experience from the H70 studies is that this is a minor 
problem. Most participants take part in most examina-
tions, and participants in previous cohorts have returned 
to follow-up examinations over several decades generating 
high response rates. In addition, participants could opt to 
take the examination over several days, and home visits 
were also offered as an alternative.
Another challenge is to keep response rates as high as 
possible to secure representativeness. Worldwide, the will-
ingness to participate in scientific studies has decreased 
dramatically during the last decades [82]. Previous H70 
studies yielded declining response rates from 85% in 
1971–72, to 81% in 1976–77, 77% in 1981–82, and 70% 
in 2000. This declining trend was broken in 2014–16 
(response rate of 72%), which may be due to intensified 
and repeated recruitment efforts. A common reason for 
non-participation in 2014–16 was suffering from an illness 
or injury that made it difficult to participate. However, 
another common reason was the view that participating 
in the H70 study would not generate any added value as 
the individual already had regular check-ups in primary 
care, and expressed feeling in control over own health. In 
addition, a few expressed being too healthy and suggested 
that we instead should focus on persons in need of health 
care. Thus, reasons for declining included both being too 
ill and being too healthy. This may have generated a sam-
ple with diverse health status. Relatives/friends declined 
participation on behalf of the invited persons in 33 cases, 
sometimes also after that the individual had agreed to par-
ticipate. Although we accepted this on all occasions, it can 
be questioned in cases in which the mental health of the 
potential participant is uncompromised. Another factor, 
which may hamper representativeness, is that participants 
needed to be able to speak Swedish, as we did not have 
resources to use translators. In addition, translators may 
not be optimal with the very sensitive questions asked 
in this study, e.g. the psychiatric interview. We will thus 
not be able to generalize our findings to persons who do 
not speak Swedish. However, the proportion born outside 
Sweden in our study (16%) is only slightly lower than that 
of the total same-age population in Gothenburg (19%, Sta-
tistics Sweden).
A third challenge with epidemiological studies conducted 
over several decades, by several generations of researchers, 
is to keep measurements and assessments as consistent as 
possible to enhance the possibilities of comparisons between 
birth cohorts and examination years. The H70-studies have 
followed a strict protocol with validated methods over time. 
The PI of the study (last author IS) took part in the data col-
lection already in 1984, and was trained by the researchers 
who conducted the first studies in the 1970s. He has super-
vised and trained research staff in H70 studies in subsequent 
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examinations, including the examination of birth cohort 
1944.
A fourth challenge is that examinations were performed 
by psychiatric nurses, medical doctors or psychiatrists which 
may have affected rating consistency. We have previously 
reported good inter-rater reliability between nurses and psy-
chiatrists, e.g. regarding dementia symptoms [83].
A fifth challenge is to keep diagnoses of diseases consist-
ent and at the same time up to date. Following data collec-
tion, which comprises extensive personal examinations using 
structured interviews, all diagnoses were made by an expert 
team of experienced psychiatrists and medical doctors. In 
addition, psychiatric diagnoses were further established by 
using algorithms including individual symptoms and signs 
according to criteria in the Diagnostic and Statistical Man-
ual of Mental Disorders (DSM). This was made possible 
as symptom ratings, rather than questions about diagnoses, 
have been the core part of the studies since 1971. This ena-
bles comparisons between studies irrespective of modifica-
tions in criteria and guidelines.
Conclusion
The research gained from the Gothenburg H70 Birth Cohort 
Studies has clinical relevance in relation to prevention, early 
diagnosis, clinical course, experience of illness, under-
standing pathogenesis and prognosis. Results will increase 
our understanding of ageing and inform service develop-
ment, which may lead to enhanced quality of care for older 
persons.
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